BIONET Corp. (TPEX: 1784)
Taiwan
· Delayed Price · Currency is TWD 94.10
-1.80 (-1.88%)
Nov 21, 2024, 12:18 PM CST
BIONET Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,178 | 1,127 | 980.38 | 921.42 | 806.58 | 775.56 | Upgrade
|
| Revenue Growth (YoY) | 6.60% | 14.99% | 6.40% | 14.24% | 4.00% | 0.64% | Upgrade
|
| Cost of Revenue | 529.73 | 489.03 | 438.16 | 418.35 | 394.62 | 354.01 | Upgrade
|
| Gross Profit | 648 | 638.28 | 542.22 | 503.07 | 411.96 | 421.55 | Upgrade
|
| Selling, General & Admin | 462.91 | 433.23 | 391.95 | 385.97 | 362.51 | 365.93 | Upgrade
|
| Research & Development | 130.81 | 118.75 | 90.3 | 85.57 | 52.45 | 46.79 | Upgrade
|
| Operating Expenses | 595.36 | 553.58 | 485.39 | 471.86 | 415.77 | 413.36 | Upgrade
|
| Operating Income | 52.64 | 84.69 | 56.83 | 31.21 | -3.81 | 8.19 | Upgrade
|
| Interest Expense | -0.93 | -0.41 | -0.46 | -0.39 | -0.33 | -0.61 | Upgrade
|
| Interest & Investment Income | 21.65 | 15.03 | 8.96 | 7.37 | 8.51 | 9.82 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.42 | -0.42 | 6.29 | -2.6 | -0.69 | -1.36 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.07 | 5.56 | 4.18 | 5.41 | 6.79 | 7.65 | Upgrade
|
| EBT Excluding Unusual Items | 81.01 | 104.46 | 75.8 | 41.01 | 10.47 | 23.68 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.63 | 2.63 | -5.35 | 0.21 | -4.17 | 3.31 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0 | 0.01 | -0.03 | -0.04 | -1.23 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.16 | - | Upgrade
|
| Pretax Income | 83.63 | 107.08 | 70.46 | 41.19 | 6.42 | 25.76 | Upgrade
|
| Income Tax Expense | 22.14 | 25.69 | 16.87 | 8.55 | 5.18 | 4.94 | Upgrade
|
| Earnings From Continuing Operations | 61.5 | 81.4 | 53.59 | 32.64 | 1.25 | 20.83 | Upgrade
|
| Minority Interest in Earnings | -5.77 | -3 | -15.62 | -6.02 | 11.5 | -14.02 | Upgrade
|
| Net Income | 55.72 | 78.4 | 37.97 | 26.62 | 12.74 | 6.8 | Upgrade
|
| Net Income to Common | 55.72 | 78.4 | 37.97 | 26.62 | 12.74 | 6.8 | Upgrade
|
| Net Income Growth | -33.46% | 106.47% | 42.62% | 108.96% | 87.29% | -71.92% | Upgrade
|
| Shares Outstanding (Basic) | 50 | 50 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | -0.63% | -0.12% | -0.54% | 0.14% | -0.07% | -3.75% | Upgrade
|
| EPS (Basic) | 1.10 | 1.55 | 0.75 | 0.52 | 0.25 | 0.13 | Upgrade
|
| EPS (Diluted) | 1.10 | 1.55 | 0.75 | 0.52 | 0.25 | 0.13 | Upgrade
|
| EPS Growth | -32.97% | 107.51% | 42.86% | 108.83% | 91.58% | -71.43% | Upgrade
|
| Free Cash Flow | 75.99 | 133.05 | 65.78 | 3.71 | 46.83 | -8.93 | Upgrade
|
| Free Cash Flow Per Share | 1.51 | 2.62 | 1.30 | 0.07 | 0.92 | -0.18 | Upgrade
|
| Dividend Per Share | 0.663 | 0.663 | 0.654 | 0.448 | 0.168 | 0.121 | Upgrade
|
| Dividend Growth | 1.44% | 1.44% | 45.83% | 166.63% | 38.47% | -53.58% | Upgrade
|
| Gross Margin | 55.02% | 56.62% | 55.31% | 54.60% | 51.08% | 54.35% | Upgrade
|
| Operating Margin | 4.47% | 7.51% | 5.80% | 3.39% | -0.47% | 1.06% | Upgrade
|
| Profit Margin | 4.73% | 6.95% | 3.87% | 2.89% | 1.58% | 0.88% | Upgrade
|
| Free Cash Flow Margin | 6.45% | 11.80% | 6.71% | 0.40% | 5.81% | -1.15% | Upgrade
|
| EBITDA | 80.64 | 109.06 | 83.41 | 55.17 | 23.41 | 34.71 | Upgrade
|
| EBITDA Margin | 6.85% | 9.67% | 8.51% | 5.99% | 2.90% | 4.47% | Upgrade
|
| D&A For EBITDA | 28 | 24.37 | 26.59 | 23.96 | 27.21 | 26.52 | Upgrade
|
| EBIT | 52.64 | 84.69 | 56.83 | 31.21 | -3.81 | 8.19 | Upgrade
|
| EBIT Margin | 4.47% | 7.51% | 5.80% | 3.39% | -0.47% | 1.06% | Upgrade
|
| Effective Tax Rate | 26.47% | 23.99% | 23.94% | 20.75% | 80.61% | 19.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.